SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ylq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1BCU_H_PRLH280_0
(ALPHA-THROMBIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
6 / 9 ASP H 189
SER H 195
VAL H 213
TRP H 215
GLY H 216
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.41A 1bcuH-4ylqH:
35.3
1bcuH-4ylqH:
35.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DWC_H_MITH1_1
(ALPHA-THROMBIN
(LARGE SUBUNIT))
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 9 HIS H  57
ASP H 189
SER H 195
TRP H 215
GLY H 226
0Z7  H 501 (-2.6A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.0A)
0.49A 1dwcH-4ylqH:
34.6
1dwcH-4ylqH:
35.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ETR_H_MITH1_1
(EPSILON-THROMBIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
7 / 12 HIS H  57
ASP H 189
SER H 195
VAL H 213
TRP H 215
GLY H 216
GLY H 226
0Z7  H 501 (-2.6A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.63A 1etrH-4ylqH:
34.5
1etrH-4ylqH:
36.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1F5L_A_AMRA301_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
6 / 8 ASP H 189
SER H 190
SER H 195
VAL H 213
GLY H 216
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.42A 1f5lA-4ylqH:
34.1
1f5lA-4ylqH:
32.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JGL_L_ESTL911_1
(IG GAMMA-1-CHAIN
IG KAPPA-CHAIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 10 TRP H 207
GLY H 205
LEU H 130
TYR H 208
HIS H 199
None
1.36A 1jglH-4ylqH:
undetectable
1jglL-4ylqH:
undetectable
1jglH-4ylqH:
20.91
1jglL-4ylqH:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NW3_A_ACTA600_0
(HISTONE
METHYLTRANSFERASE
DOT1L)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 5 LEU H 130
VAL H 133
TYR H 203
THR H 201
None
1.47A 1nw3A-4ylqH:
undetectable
1nw3A-4ylqH:
19.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TNL_A_TPAA900_1
(TRYPSIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
6 / 6 ASP H 189
SER H 190
SER H 195
VAL H 213
GLY H 216
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.26A 1tnlA-4ylqH:
35.4
1tnlA-4ylqH:
40.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BR4_D_SAMD301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
3 / 3 LYS H  16
ASP H  60
ASP H 194
None
0Z7  H 501 ( 4.2A)
None
0.95A 2br4D-4ylqH:
undetectable
2br4D-4ylqH:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IGT_C_SAMC1003_1
(SAM DEPENDENT
METHYLTRANSFERASE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 4 ASP H 189
ASP H 186
ASP H 146
GLY H 223
0Z7  H 501 (-2.3A)
None
None
POL  H 509 ( 4.0A)
1.36A 2igtC-4ylqH:
undetectable
2igtC-4ylqH:
21.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OTV_A_NCAA1301_0
(CATIONIC TRYPSIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
6 / 6 ASP H 189
SER H 190
SER H 195
VAL H 213
GLY H 216
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.21A 2otvA-4ylqH:
35.6
2otvA-4ylqH:
40.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OUZ_A_C3DA999_0
(ESTROGEN RECEPTOR)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 LEU H  46
THR H  45
LEU H 105
LEU H 106
LEU H 108
None
0.98A 2ouzA-4ylqH:
undetectable
2ouzA-4ylqH:
19.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P16_A_GG2A298_1
(COAGULATION FACTOR X
(EC 3.4.21.6)
(STUART FACTOR)
(STUART-PROWER
FACTOR))
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
7 / 12 ASP H 189
SER H 195
VAL H 213
TRP H 215
GLY H 216
GLY H 226
TYR H 228
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
None
0.30A 2p16A-4ylqH:
38.8
2p16A-4ylqH:
40.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2W26_A_RIVA1001_1
(ACTIVATED FACTOR XA
HEAVY CHAIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
8 / 12 ASP H 189
SER H 195
VAL H 213
TRP H 215
GLY H 216
GLY H 218
GLY H 226
TYR H 228
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.5A)
0Z7  H 501 (-3.0A)
None
0.32A 2w26A-4ylqH:
38.8
2w26A-4ylqH:
40.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_2
(ADENOSYLHOMOCYSTEINA
SE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 5 LEU H 209
GLN H  30
THR H  45
THR H 201
None
1.28A 2zj0C-4ylqH:
undetectable
2zj0C-4ylqH:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 4 LEU H 209
GLN H  30
THR H  45
THR H 201
None
1.31A 2zj0D-4ylqH:
undetectable
2zj0D-4ylqH:
20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CE6_B_ADNB500_2
(ADENOSYLHOMOCYSTEINA
SE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 5 LEU H 209
GLN H  30
THR H  45
THR H 201
None
1.31A 3ce6B-4ylqH:
undetectable
3ce6B-4ylqH:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GY3_A_PNTA246_0
(CATIONIC TRYPSIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
7 / 11 HIS H  57
ASP H 189
SER H 190
SER H 195
TRP H 215
GLY H 216
GLY H 226
0Z7  H 501 (-2.6A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.40A 3gy3A-4ylqH:
35.2
3gy3A-4ylqH:
40.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HM1_A_J3ZA2_1
(ESTROGEN RECEPTOR)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 LEU H  46
THR H  45
LEU H 105
LEU H 106
LEU H 108
None
1.09A 3hm1A-4ylqH:
undetectable
3hm1A-4ylqH:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEE_D_30BD500_1
(GENOME POLYPROTEIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 HIS H  57
ASP H 102
LYS H 192
GLY H 193
SER H 195
0Z7  H 501 (-2.6A)
0Z7  H 501 (-3.3A)
0Z7  H 501 (-2.9A)
0Z7  H 501 (-3.2A)
0Z7  H 501 (-1.4A)
1.13A 3keeD-4ylqH:
10.4
3keeD-4ylqH:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NVK_I_SAMI228_0
(FIBRILLARIN-LIKE
RRNA/TRNA
2'-O-METHYLTRANSFERA
SE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 LYS H  16
GLY H 197
ILE H 212
ALA H  55
ASP H 194
None
1.10A 3nvkI-4ylqH:
undetectable
3nvkI-4ylqH:
21.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXF_A_4APA9_1
(CATIONIC TRYPSIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
6 / 6 SER H 190
SER H 195
VAL H 213
TRP H 215
GLY H 216
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.37A 3rxfA-4ylqH:
14.5
3rxfA-4ylqH:
40.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXH_A_HSMA7_1
(CATIONIC TRYPSIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 5 ASP H 189
SER H 190
SER H 195
VAL H 213
GLY H 226
0Z7  H 501 (-2.3A)
0Z7  H 501 (-2.3A)
0Z7  H 501 (-1.4A)
0Z7  H 501 ( 4.7A)
0Z7  H 501 (-3.0A)
0.33A 3rxhA-4ylqH:
35.6
3rxhA-4ylqH:
40.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VAS_B_ADNB401_1
(PUTATIVE ADENOSINE
KINASE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 LEU H  64
GLY H 197
GLY H 196
LEU H 106
GLY H 142
None
0.95A 3vasB-4ylqH:
undetectable
3vasB-4ylqH:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1G_A_LNLA701_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 PHE H  59
ILE H 212
GLY H 193
GLY H  44
LEU H  33
None
None
0Z7  H 501 (-3.2A)
None
None
1.06A 4e1gA-4ylqH:
undetectable
4e1gA-4ylqH:
16.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HFP_D_15UD402_1
(PROTHROMBIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 HIS H  57
ASP H 189
VAL H 213
TRP H 215
GLY H 226
0Z7  H 501 (-2.6A)
0Z7  H 501 (-2.3A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.0A)
0.26A 4hfpD-4ylqH:
34.4
4hfpD-4ylqH:
35.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
4 / 7 ASP H  77
GLU H  80
VAL H  67
GLU H  70
None
CA  H 502 (-3.3A)
None
CA  H 502 (-2.8A)
1.06A 4hvrA-4ylqH:
undetectable
4hvrA-4ylqH:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QDJ_A_SAMA301_0
(MAGNESIUM-PROTOPORPH
YRIN
O-METHYLTRANSFERASE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 VAL H 231
GLY H  44
ILE H 103
LEU H 105
LEU H  46
None
0.98A 4qdjA-4ylqH:
undetectable
4qdjA-4ylqH:
22.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RN6_B_15UB301_1
(THROMBIN HEAVY CHAIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 HIS H  57
VAL H 213
TRP H 215
GLY H 216
GLY H 226
0Z7  H 501 (-2.6A)
0Z7  H 501 ( 4.7A)
TMA  H 508 ( 3.9A)
0Z7  H 501 (-3.4A)
0Z7  H 501 (-3.0A)
0.33A 4rn6B-4ylqH:
29.5
4rn6B-4ylqH:
35.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AOX_C_ACTC1001_0
(ALU JO CONSENSUS RNA
SIGNAL RECOGNITION
PARTICLE 14 KDA
PROTEIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
3 / 3 TYR H 179
THR H 229
THR H 177
None
0.56A 5aoxB-4ylqH:
undetectable
5aoxB-4ylqH:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AOX_F_ACTF1001_0
(ALU JO CONSENSUS RNA
SIGNAL RECOGNITION
PARTICLE 14 KDA
PROTEIN)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
3 / 3 TYR H 179
THR H 229
THR H 177
None
0.61A 5aoxE-4ylqH:
undetectable
5aoxE-4ylqH:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_A_C2FA3001_0
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
4ylq COAGULATION FACTOR
VII

(Homo
sapiens)
5 / 12 GLY H 226
LEU H 121
VAL H  53
SER H 195
ILE H 212
0Z7  H 501 (-3.0A)
None
None
0Z7  H 501 (-1.4A)
None
1.06A 5vopA-4ylqH:
undetectable
5vopA-4ylqH:
23.51